Nicholas Maestas
Director of Finance/CFO presso TEMPEST THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Nicholas Maestas is currently the Secretary, Vice President-Finance & Strategy at Tempest Therapeutics, Inc. He previously worked as the Senior Director-Corporate Development & Operations at Immune Design Corp.
from 2014 to 2019 and as the Head-Financial Planning & Analysis at Alector, Inc. from 2019 to 2021.
Mr. Maestas completed his undergraduate degree at the University of California, Berkeley and holds an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
03/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Nicholas Maestas
Società | Posizione | Inizio |
---|---|---|
TEMPEST THERAPEUTICS, INC. | Director of Finance/CFO | 12/07/2021 |
Precedenti posizioni note di Nicholas Maestas
Società | Posizione | Fine |
---|---|---|
ALECTOR, INC. | Corporate Officer/Principal | 01/07/2021 |
IMMUNE DESIGN CORP | Corporate Officer/Principal | 01/07/2019 |
Formazione di Nicholas Maestas
University of California, Berkeley | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ALECTOR, INC. | Health Technology |
TEMPEST THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
- Borsa valori
- Insiders
- Nicholas Maestas